Preliminary in vitro efficacy and toxicities studies of the herpes simplex thymidine kinase gene system for the treatment of breast cancer

Hybridoma

Volumn 14, Issue 2, 1995, Pages 143-147

  Link Jr , C J ^a   Kolb, E M ^a   Muldoon, R R ^a  

^a Iowa Cancer Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GANCICLOVIR; INTERLEUKIN 2; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BRAIN CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RETROVIRUS;

ANIMALIA; HERPES; MUS MUSCULUS; UNIDENTIFIED RETROVIRUS;

EID: 0029004906     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1995.14.143     Document Type: Conference Paper

References (0)